{"id":173359,"date":"2025-09-27T18:19:34","date_gmt":"2025-09-27T18:19:34","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/173359\/"},"modified":"2025-09-27T18:19:34","modified_gmt":"2025-09-27T18:19:34","slug":"widow-vs-companion-vs-will-etlegalworld","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/173359\/","title":{"rendered":"Widow vs. Companion vs. Will, ETLegalWorld"},"content":{"rendered":"<p>                                        <img fetchpriority=\"high\" decoding=\"async\" width=\"590\" height=\"442\" class=\"unveil\" loading=\"eager\" style=\"width:100%;max-height:100%\" src=\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2025\/09\/124048444.cms.jpeg\" captionrendered=\"1\" alt=\"Illustrative\"\/>Illustrative The Aristo empire\u2014worth more than INR 40,000 crore\u2014now sits at the centre of one of Delhi\u2019s most bitter inheritance disputes. Its founder, Dr. Mahendra Prasad (DMP), industrialist, seven-time parliamentarian, and political powerbroker, left behind more than a pharmaceutical fortune. He left two women: a wife of sixty years who says the empire began with the gold she brought into the marriage, and a long-time companion who shared his final decades and held joint assets with him.<\/p>\n<p>Their claims collide with a 2011 <a id=\"32911\" type=\"General\" weightage=\"20\" keywordseo=\"will\" source=\"Orion\" class=\"news-keywords\" href=\"https:\/\/legal.economictimes.indiatimes.com\/tag\/will\" rel=\"nofollow noopener\" target=\"_blank\">will<\/a> that allegedly erased the widow from succession. Around them are DMP\u2019s children and extended family, each positioning themselves in a fight that will decide not just who inherits Aristo, but whose story of its origins prevails in court.<\/p>\n<p>The numbers are staggering even by India\u2019s high-stakes corporate standards. Fixed deposits alone account for nearly \u20b93,500 crore. There are sprawling real estate holdings in Delhi, Mumbai, and Bihar. Then come the crown jewels: controlling stakes in Aristo Pharmaceuticals, Aristo Laboratories, and Mapra Laboratories\u2014companies woven deep into the fabric of India\u2019s generic drugs supply.<\/p>\n<p>With so much at play, the question of \u201cwho inherits?\u201d has split the family into factions and drawn the judiciary into years of guardianship and probate proceedings.<\/p>\n<p>Factions and Fault LinesOn one side stands <a id=\"29012892\" type=\"General\" weightage=\"20\" keywordseo=\"satula-devi\" source=\"keywords\" class=\"news-keywords\" href=\"https:\/\/legal.economictimes.indiatimes.com\/tag\/satula+devi\" rel=\"nofollow noopener\" target=\"_blank\">Satula Devi<\/a>, DMP\u2019s wife of six decades, who passed away in 2022. She claimed the entire Aristo empire was built on her stridhan\u20144.5 kilograms of gold given to her at marriage in 1960. By that argument, she was not just a beneficiary but the legal owner of the family fortune. In the alternative, she sought a quarter share under natural succession laws.Arrayed against her is <a id=\"29012890\" type=\"General\" weightage=\"20\" keywordseo=\"uma-devi\" source=\"keywords\" class=\"news-keywords\" href=\"https:\/\/legal.economictimes.indiatimes.com\/tag\/uma+devi\" rel=\"nofollow noopener\" target=\"_blank\">Uma Devi<\/a>, DMP\u2019s long-time companion, who lived with him in later years. After DMP\u2019s dementia diagnosis in 2019, large sums were shifted into joint accounts in her name\u2014a move the family contests.<\/p>\n<p>Then came the third faction: <a id=\"29012893\" type=\"General\" weightage=\"20\" keywordseo=\"kanchana-rai\" source=\"keywords\" class=\"news-keywords\" href=\"https:\/\/legal.economictimes.indiatimes.com\/tag\/kanchana+rai\" rel=\"nofollow noopener\" target=\"_blank\">Kanchana Rai<\/a>, the daughter-in-law, who produced a registered Will dated July 2011. In it, DMP excluded his wife and surviving sons entirely, leaving everything to her two sons &#8211; Achintya and Aradhya Rai, his grandsons. She is the Executor of that Will and has petitioned for probate.<\/p>\n<p>To prevent the wealth from vanishing amid this tug-of-war, the Delhi High Court appointed Justice Rajiv Sahai Endlaw (Retd.) as the sole guardian of the estate.<\/p>\n<p>Guardianship and DementiaThe first skirmishes appeared in 2019, when Ranjit Sharma filed a habeas corpus petition, alleging that Uma Devi was confining his mother. Court-ordered medical examinations revealed frontotemporal dementia, confirming that DMP\u2019s mental capacity had deteriorated.<\/p>\n<p>By 2020, Satula Devi petitioned to be declared DMP\u2019s guardian, citing both medical and estate oversight reasons. The court froze transfers of assets, noting substantial sums had moved into Uma Devi\u2019s name after the dementia diagnosis. A guardianship committee of family members was constituted to manage DMP\u2019s affairs.<\/p>\n<p>After DMP\u2019s death on 27 December 2021, the committee dissolved, and Justice Endlaw was appointed sole guardian, an extraordinary step to safeguard thousands of crores while litigation over inheritance took shape.<\/p>\n<p>The Will That Shook the FamilyIn January 2022, Kanchana Rai produced a registered Will dated 18 July 2011. It named her as executor and transferred the entirety of DMP\u2019s estate to her two sons, excluding Satula Devi and her surviving sons entirely.<\/p>\n<p>For the widow, it was erasure. For lawyers, it posed a question: could a patriarch who had been diagnosed with dementia years later truly have executed a will free of coercion or misapprehension?<\/p>\n<p>Satula Devi\u2019s heirs launched a civil suit seeking ownership through stridhan or, alternatively, a one-quarter share. In 2023, a single judge dismissed the suit as barred by limitation.<\/p>\n<p>On 16 September 2025, the Delhi High Court Division Bench, comprising Justices Anil Kshetarpal and Harish Vaidyanathan Shankar, revived the widow\u2019s claim. The bench clarified that the right to reclaim stridhan arises only at death or upon a refused demand, overturning the lower court\u2019s time-barred reasoning.<\/p>\n<p>Guardianship appeals were declared infructuous given DMP\u2019s death. Crucially, the bench directed Justice Endlaw to continue as sole guardian to ensure \u201cno dissipation or alienation\u201d of assets until probate is decided.<\/p>\n<p>More importantly for business watchers, the bench revived Satula\u2019s suit, stressing that a plaint must be read holistically. A court cannot dismiss the ownership claim embedded in the stridhan argument just because a Will also exists.<\/p>\n<p>The two pending proceedings\u2014the probate petition and Satula\u2019s partition suit\u2014will now be consolidated. The stage is set for a decisive trial on whether the 2011 Will is valid and whether the Aristo fortune was truly seeded by stridhan.<\/p>\n<p>Satula Devi was represented in the high court by Senior Advocate Vikas Singh and a team from Foresight Law Offices comprising founder and managing partner Varun Singh, senior associates Alankriti Dwivedi, Kajal Gupta and Shikher Upadhyay, and associate Somesha Gupta. <\/p>\n<p>What\u2019s NextThe next hearing on 23 September 2025 will test the 2011 will against the revived stridhan claim. The court will determine:Whether the will was valid and enforceable.Whether Satula Devi\u2019s heirs can claim ownership based on her gold contribution.Whether an administrator should be formally appointed under the Indian Succession Act.Until then, the Aristo empire remains frozen under judicial supervision\u2014guarded by Justice Endlaw, claimed by a widow\u2019s heirs, contested by a companion, and defended by a daughter-in-law armed with a disputed Will.<\/p>\n<p>Beyond family drama, the case carries serious business implications. Aristo is a major supplier of generics to hospitals and state programmes; prolonged disputes threaten governance and strategic decision-making.<\/p>\n<p>Legally, the case could set a precedent for women\u2019s proprietary rights in family businesses, particularly when contributions predate the growth of the empire. And it exposes the perils of succession planning in India\u2019s family-owned conglomerates, where vast fortunes can remain vulnerable to prolonged litigation.<\/p>\n<p>In the coming weeks, the court\u2019s rulings could reshape the legacy of one of India\u2019s largest pharmaceutical fortunes\u2014deciding not just who inherits, but whose story the law chooses to recognise.\n                                                                    <\/p>\n<p>                                    Published On Sep 22, 2025 at 05:46 PM IST<\/p>\n<p>\n                Join the community of 2M+ industry professionals.<br \/>\n                Subscribe to Newsletter to get latest insights &amp; analysis in your inbox.\n            <\/p>\n<p>                    All about ETLegalWorld industry right on your smartphone! <\/p>\n<p>                        <img decoding=\"async\" loading=\"lazy\" width=\"90\" height=\"90\" src=\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2025\/09\/legal_barcode.png\" alt=\"\"\/>                        <\/p>\n","protected":false},"excerpt":{"rendered":"Illustrative The Aristo empire\u2014worth more than INR 40,000 crore\u2014now sits at the centre of one of Delhi\u2019s most&hellip;\n","protected":false},"author":2,"featured_media":173360,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[112802,64,63,99,186,112807,112806,184,185,112805,112804,112803,1050],"class_list":{"0":"post-173359","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-personal-finance","8":"tag-aristo-pharma","9":"tag-au","10":"tag-australia","11":"tag-business","12":"tag-finance","13":"tag-inheritance-issues","14":"tag-kanchana-rai","15":"tag-personal-finance","16":"tag-personalfinance","17":"tag-satula-devi","18":"tag-satula-devis","19":"tag-uma-devi","20":"tag-will"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/173359","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=173359"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/173359\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/173360"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=173359"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=173359"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=173359"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}